ArticleFrontiers in cell and developmental biology2026
Integrated bioinformatics and machine learning to explore the common mechanisms and potential biomarkers between periodontitis and preterm birth.
Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: There is accumulating evidence suggesting an association between periodontitis (PD) and preterm birth (PTB), but the underlying mechanisms have not been fully elucidated. This study aims to explore potential biomarkers and mechanisms between PD and PTB through integrated bioinformatics and machine learning approaches. Methods: Datasets for PD (GSE16134 and GSE10334) and PTB (GSE203507, GSE174415, GSE18809, GSE73685 and GSE120480) were acquired from Gene Expression Omnibus (GEO). Then we performed Weighted gene co-expression network analysis (WGCNA), differential expressed genes (DEGs) analysis and three machine learning algorithms to identify cross-talk genes. To evaluate the potential of cross-talk genes as diagnostic biomarkers for PD and PTB, receiver operating characteristic (ROC) curve analysis and expression analysis were conducted. We then conducted functional enrichment analysis to elucidate the biological roles of the common DEGs. Single-sample gene set enrichment analysis (ssGSEA) assessed immune cell patterns of PD and PTB and biomarker-immune cell correlations. Additionally, we constructed a protein-protein interaction (PPI) network and further analyzed potential biomarkers using the cytoHubba plugin in Cytoscape software. Ultimately, the expression of the core genes in the PD animal model were validated. Results: We identified four cross-talk genes through the integrated analysis. Common DEGs were mainly concentrated in immune-related pathways. Following expression analysis and ROC curve analysis, we identified two genes (CD53 and BIN2) as potential biomarkers for PD and PTB. These genes were upregulated in disease groups compared to controls and exhibited strong diagnostic performance (AUC > 0.7) in both the training and validation cohorts. Moreover, CD53 and BIN2 displayed high connectivity within the PPI network. Immune cell infiltration analysis revealed that multiple immune cell types exhibited consistent upregulation in both diseases. In the PD model, consistent upregulation of CD53 and BIN2 was observed in the maxillary bone. Conclusion: We identified two potential biomarkers (CD53 and BIN2) for the concurrent diagnosis of PD and PTB, and suggested that the potential common mechanism of these two diseases may be correlated with the immune response. This study provides novel insights into the pathogenesis of both diseases, thereby informing future preventive, diagnostic and therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.